Entrepreneur
Costplusdrugs.com
Our lab uses experimental and computational methods to design de novo proteins | @Stanford
Interested in drug development, microbial ecology, systems biology, & urbanism. I develop bacterial consortia as drugs: https://www.vedantabio.com
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18
All opinions are mine; I don’t speak for my employer in any way.
Axial https://linktr.ee/axialxyz
Microbial evolutionary ecologist
CSO of pharmabiome.com
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
Microbe host, researcher, microbiome drug developer at Vedanta Biosciences
Ex-academic (many years ago) & biotech entrepreneur, including at Biovex & $REPL inc
CTO at Kimia Therapeutics. Formerly SVP AI at Recursion.
https://ihaque.org
https://x.com/ImranSHaque
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
CEO of Eledon Pharmaceuticals $ELDN. Physician passionate about pioneering medicines, patient advocacy and public health. Opinions are my own.
Entrepreneur, Board Member, Author, Physician
Co-founder of nine biotech startups developing novel platforms and therapies. Biotech Board member and advisor; Author of Quiet Leader Loud Results (Post Hill Press, 2022) www.quietleader.com
Chief Scientific Officer at Alltrna. Former CSO at Synlogic, Metera Pharmaceuticals and Pulmatrix. Microbiologist, immunologist and drug developer. Opinions are my own.
Health economist writing about HEOR/market access, drug development, biopharma
Http://refiningvalue.substack.com
Science (mostly #biotech), Jokes, other interesting things. Investor relations. Boston. Dad.
Computational biologist in industry; views are my own. Wide interests in genomics, immunotherapy, pharmacology, biotech, single cell methods, and reproductive biology.
Biotech reporter, San Francisco Business Times
